Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy. (Q38071981)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

review article

1 reference

title

Importance of detecting multidrug resistance proteins in acute leukemia prognosis and therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292860%20AND%20SRC:MED&resulttype=core&format=json

Gabriela Schneider-Rauber

21 February 2020

main subject

multiple drug resistance

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292860%20AND%20SRC:MED&resulttype=core&format=json

Maria Cláudia Santos-Silva

21 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Ana Carolina Rabello de Moraes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Caroline Klein Maranho

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

language of work or name

1 reference

4 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292860%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Laboratory Analysis

21 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

62-71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292860%20AND%20SRC:MED&resulttype=core&format=json

Resistance mechanisms associated with altered intracellular distribution of anticancer agents.

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Mechanisms of drug resistance in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

ATP-binding cassette (ABC) transporters in normal and pathological lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

The human ATP-binding cassette (ABC) transporter superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Analysis of P-glycoprotein-mediated membrane transport in human peripheral blood lymphocytes using the UIC2 shift assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Flip-flop: the transmembrane translocation of lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Structure of a bacterial multidrug ABC transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Mechanisms of cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

MDR1 gene expression and treatment outcome in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

ATP binding cassette transporters and drug resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

The structure of the multidrug resistance protein 1 (MRP1/ABCC1). crystallization and single-particle analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

MRP subfamily transporters and resistance to anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Adriamycin resistance in HL60 cells in the absence of detectable P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

A family of drug transporters: the multidrug resistance-associated proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Mutations of charged amino acids in or near the transmembrane helices of the second membrane spanning domain differentially affect the substrate specificity and transport activity of the multidrug resistance protein MRP1 (ABCC1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Structural, mechanistic and clinical aspects of MRP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Transport of glutathione and glutathione conjugates by MRP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Frequent coexpression of MRP/GS-X pump and gamma-glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Expression of MRP1 gene in acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Role of the lung resistance-related protein (LRP) in the drug sensitivity of cultured tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Major vault protein LRP-related multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Solution structure of a two-repeat fragment of major vault protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Up-regulation of vaults may be necessary but not sufficient for multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Multidrug resistance protein expression of adult T-cell leukemia/lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Messenger RNA analysis of the multidrug resistance related protein (MRP1) and the lung resistance protein (LRP) in de novo and relapsed childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Monitoring of cellular resistance to cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Drug resistance: still a daunting challenge to the successful treatment of AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

ABC multidrug transporters: structure, function and role in chemoresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.21563

Acute myelogenous leukemia

21 January 2018

1 reference

12 December 2020

Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels

1 reference

12 December 2020

Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells

1 reference

12 December 2020

Functional reconstitution of substrate transport by purified multidrug resistance protein MRP1 (ABCC1) in phospholipid vesicles

1 reference

12 December 2020

[Clinical significance of multidrug resistance in acute leukemias]

1 reference

12 December 2020

Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study

1 reference

12 December 2020

Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia

1 reference

12 December 2020

Major vault protein LRP-related multidrug resistance

1 reference

12 December 2020

Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications.

1 reference

12 December 2020

Expression of MDR1, LRP, BCRP and Bcl-2 genes at diagnosis of childhood all: comparison with MRD status after induction therapy

1 reference

12 December 2020

Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression

1 reference

12 December 2020

Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.

1 reference

12 December 2020

Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs.

1 reference

12 December 2020

Role of the MRP1/ABCC1 multidrug transporter protein in cancer

1 reference

12 December 2020

Expression of members of the multidrug resistance protein family in human term placenta

1 reference

12 December 2020

Quantitative analysis of a MDR1 transcript for prediction of drug resistance in acute leukemia

1 reference

12 December 2020

ABCB1 genetic variation and P-glycoprotein expression/activity in a cohort of Brazilian acute myeloid leukemia patients

1 reference

12 December 2020

ABCB1 modulation does not circumvent drug extrusion from primitive leukemic progenitor cells and may preferentially target residual normal cells in acute myelogenous leukemia

1 reference

12 December 2020

Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.

1 reference

12 December 2020

Expression of lung resistance protein and multidrug resistance-related protein (MRP1) in pediatric acute lymphoblastic leukemia

1 reference

12 December 2020

Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia

1 reference

12 December 2020

P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death

1 reference

12 December 2020

Topology mapping of the amino-terminal half of multidrug resistance-associated protein by epitope insertion and immunofluorescence

1 reference

12 December 2020

Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine

1 reference

12 December 2020

P-glycoprotein is an independent prognostic factor predicting relapse in childhood acute lymphoblastic leukaemia: results of a 6-year prospective study

1 reference

12 December 2020

Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia

1 reference

12 December 2020

Potentiatied antitumor effectiveness of combined chemo-immunotherapy with interleukin-12 and 5-fluorouracil of L1210 leukemia in vivo

1 reference

12 December 2020

Identifiers

DOI

10.1002/JCLA.21563

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23292860%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

PubMed publication ID

23292860

1 reference